TOMI Environmental Solutions Announces Major New Customer Win for 2025

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, has secured significant orders from a major eye health company. The customer placed orders for multiple Surface Units and disinfection carts for facilities in South Carolina and Florida, with expected total purchases of $385,000 for 2025.

The South Carolina facility has successfully completed validation testing, demonstrating SteraMist's effectiveness against Geobacillus stearothermophilus spores. The Florida facility is scheduled for qualification using the same methodology. This expansion validates TOMI's Binary Ionization Technology® (BIT™) platform, which uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection in regulated environments.

Positive

• New customer orders worth $385,000 for 2025
• Successful validation testing at South Carolina facility
• Expansion to second facility (Florida) demonstrates strong product acceptance
• Technology proven effective against challenging industry benchmark organisms

Negative

• Revenue from single customer represents significant concentration risk
• Future orders dependent on successful Florida facility qualification

Insights

Medical Technology & Business Development Specialist

TOMI secures $385,000 in orders from major eye health company, demonstrating technology validation and potential facility expansion opportunities.

TOMI Environmental Solutions has secured a significant customer win with a global leader in eye health, representing approximately $385,000 in 2025 revenue from equipment, solution, and support services. This development carries substantial weight beyond the immediate financial impact.

The sequential facility adoption pattern is particularly noteworthy. After initially deploying SteraMist units in South Carolina, the customer has now expanded to their Florida location—suggesting a successful implementation that's being replicated across their network. This expansion model often indicates strong product satisfaction and could potentially lead to additional facility adoptions.

The validation success against Geobacillus stearothermophilus spores is technically significant. These bacterial spores are among the most challenging disinfection targets and are frequently used as biological indicators in sterilization validation. Successfully demonstrating repeatable efficacy against this microorganism positions TOMI's technology favorably with FDA requirements that emphasize complete decontamination of hard-to-clean equipment.

The timing aligns with heightened focus on contamination control in healthcare facilities. In recent years, regulatory bodies have increased scrutiny on sterilization protocols, particularly for equipment with complex surfaces where traditional disinfection methods often fail. TOMI's ionized Hydrogen Peroxide (iHP) technology addresses this specific challenge by penetrating small cracks and crevices.

This customer win demonstrates product-market fit in the demanding healthcare sector and establishes a potential reference customer that could accelerate sales cycles with similar prospects. The relatively modest $385,000 figure may understate the strategic importance of establishing this relationship with a globally recognized leader that could lead to recurring revenue through ongoing solution purchases and expanded facility deployments.

FREDERICK, Md., Aug. 12, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it has received significant purchase orders from a globally recognized leader in eye health.

The company had placed an order for multiple Surface Units and disinfection carts for its South Carolina facility earlier in the year. In the third quarter of 2025, a second order was placed for the Florida facility. Notably, the South Carolina validation package was successfully completed, demonstrating repeatable, high-quality surface treatment results.

As seen in recent years, the FDA has emphasized the importance of complete decontamination of hard to clean equipment with technologies which can penetrate the smallest cracks and crevices. SteraMist successfully passed repeatable trials against Geobacillus stearothermophilus spores, a challenging industry benchmark for manual surface spraying, further demonstrating the competitive advantage and reliability of its iHP technology. The Florida facility is planned to undergo qualification in the near term using the same methodology as the prior facility.

The Company expects that the total amount of purchases from this customer will be approximately $385,000 for 2025, comprising of SteraMist iHP equipment, BIT Solution, and support services. This engagement underscores strong customer validation and growing demand for TOMI’s validated disinfection solutions across multiple facilities.

"We are incredibly proud to expand our partnership with this leader in global eye health," said Jim Reynolds, TOMI Manufacturing Sales Representative, President of ProEx Services. "This repeat business is a powerful testament to the performance and reliability of our iHP disinfection systems and the value they bring to customers operating in the most demanding regulatory environments. We are committed to quality and safety at their facilities and expanding our partnership to include their other locations.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, the expected purchase amount from customer and statements relating to TOMI’s products to serve healthcare sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com

FAQ

What is the value of TOMI Environmental Solutions (TOMZ) new customer orders for 2025?

TOMI secured orders totaling $385,000 for 2025, including SteraMist iHP equipment, BIT Solution, and support services from a global eye health company.

What facilities has TOMI Environmental Solutions (TOMZ) secured orders for in 2025?

TOMI received orders for facilities in South Carolina and Florida, with the South Carolina facility already completing successful validation testing.

What technology does TOMI Environmental Solutions use in its disinfection systems?

TOMI uses Binary Ionization Technology® (BIT™) platform with ionized Hydrogen Peroxide (iHP™) technology, developed under a DARPA defense grant.

How effective is TOMI's SteraMist technology in disinfection?

SteraMist demonstrated successful performance against Geobacillus stearothermophilus spores, a challenging industry benchmark for manual surface spraying.

What markets does TOMI Environmental Solutions (TOMZ) serve?

TOMI serves multiple sectors including hospitals, medical facilities, biosafety labs, pharmaceutical facilities, commercial buildings, schools, restaurants, meat processing facilities, and emergency services.